Literature DB >> 22152573

Determinants of poor outcome after aneurysmal subarachnoid hemorrhage when both clipping and coiling are available: Prospective Registry of Subarachnoid Aneurysms Treatment (PRESAT) in Japan.

Waro Taki1, Nobuyuki Sakai, Hidenori Suzuki.   

Abstract

OBJECTIVE: To examine current determinants of poor outcome after aneurysmal subarachnoid hemorrhage (SAH) when ruptured aneurysms are treated with either microsurgery (clipping) or endovascular treatment (coiling) depending on each patient's characteristics.
METHODS: Between March 2006 and February 2007, 534 patients with SAH were enrolled in the Prospective Registry of Subarachnoid Aneurysms Treatment (PRESAT) project. Patients were treated according to the preference of investigators who were experienced in performing both clipping and coiling. Factors influencing poor outcome (12-month modified Rankin Scale [mRS], 3-6) were determined using multivariate logistic regression analyses.
RESULTS: In this cohort, 32.4% of patients were World Federation of Neurosurgical Societies (WFNS) grade IV-V, and 28.1% had a poor outcome. Clipping was preferably performed for small aneurysms with a wide neck and for middle cerebral artery (MCA) aneurysms, whereas coiling was preferred for larger, internal carotid artery (ICA) and posterior circulation aneurysms. In addition to increasing age, admission WFNS grade IV-V, preadmission aneurysmal rerupture, vasospasm-induced cerebral infarct, pneumonia, sepsis, shunt-dependent hydrocephalus and seizure, postclipping hemorrhagic complications (odds ratio 4.8, 95% confidence interval 1.5-15.3, P < 0.01), and postcoiling ischemic complications (odds ratio 4.4, 95% confidence interval 1.3-15.2, P < 0.05) significantly caused poor outcomes, although the complications did not affect mortality. Type of treatment modality and size and location of aneurysms did not influence outcome.
CONCLUSIONS: Introducing an endovascular treatment option has made aneurysm characteristics less important to outcome, but procedural complications are problematic and should be reduced to improve outcome.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22152573     DOI: 10.1016/j.wneu.2011.04.026

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  19 in total

1.  What is early brain injury?

Authors:  Hidenori Suzuki
Journal:  Transl Stroke Res       Date:  2014-12-16       Impact factor: 6.829

2.  Effects of Toll-Like Receptor 4 Antagonists Against Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Mice.

Authors:  Fumihiro Kawakita; Masashi Fujimoto; Lei Liu; Fumi Nakano; Yoshinari Nakatsuka; Hidenori Suzuki
Journal:  Mol Neurobiol       Date:  2016-10-13       Impact factor: 5.590

3.  Factors associated with clinical and radiological status on admission in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Daniel W Zumofen; Michel Roethlisberger; Rita Achermann; Schatlo Bawarjan; Martin N Stienen; Christian Fung; Donato D'Alonzo; Nicolai Maldaner; Andrea Ferrari; Marco V Corniola; Daniel Schoeni; Johannes Goldberg; Daniele Valsecchi; Thomas Robert; Rodolfo Maduri; Martin Seule; Jan-Karl Burkhardt; Serge Marbacher; Philippe Bijlenga; Kristine A Blackham; Heiner C Bucher; Luigi Mariani; Raphael Guzman
Journal:  Neurosurg Rev       Date:  2018-02-10       Impact factor: 3.042

4.  Factors predicting retreatment and residual aneurysms at 1 year after endovascular coiling for ruptured cerebral aneurysms: Prospective Registry of Subarachnoid Aneurysms Treatment (PRESAT) in Japan.

Authors:  Waro Taki; Nobuyuki Sakai; Hidenori Suzuki
Journal:  Neuroradiology       Date:  2011-08-23       Impact factor: 2.804

5.  Higher Cerebrospinal Fluid pH may Contribute to the Development of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage.

Authors:  Hidenori Suzuki; Masato Shiba; Yoshinari Nakatsuka; Fumi Nakano; Hirofumi Nishikawa
Journal:  Transl Stroke Res       Date:  2016-09-14       Impact factor: 6.829

6.  Endovascular treatment of 300 consecutive middle cerebral artery aneurysms: clinical and radiologic outcomes.

Authors:  A M Mortimer; M D Bradley; P Mews; A J Molyneux; S A Renowden
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-14       Impact factor: 3.825

7.  Comparative effectiveness of ruptured cerebral aneurysm therapies: propensity score analysis of clipping versus coiling.

Authors:  J S McDonald; R J McDonald; J Fan; D F Kallmes; G Lanzino; H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-18       Impact factor: 3.825

8.  Milrinone via lumbar subarachnoid catheter for vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Nobutake Sadamasa; Kazumichi Yoshida; Osamu Narumi; Masaki Chin; Sen Yamagata
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

9.  Prediction of Delayed Cerebral Ischemia with Cerebral Angiography: A Meta-Analysis.

Authors:  Gyanendra Kumar; Oana M Dumitrascu; Chia-Chun Chiang; Cumara B O'Carroll; Andrei V Alexandrov
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

Review 10.  Cerebrovascular pathophysiology of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Authors:  Hidenori Suzuki; Hideki Kanamaru; Fumihiro Kawakita; Reona Asada; Masashi Fujimoto; Masato Shiba
Journal:  Histol Histopathol       Date:  2020-09-30       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.